News

The brand of amino acid mixtures for the treatment of inborn errors of protein metabolism, Comidamed, owned by Dr. Schär, will have a new look this autumn.

If you have not done it yet, enter www.mevalia.com and discover the new website dedicated to Dr. Schär's Metabolic Nutrition brand.

Dr. Schär and its partners have presented the findings of the Re-Cereal research project at the AREA Science Park in Trieste. Around 100 representatives of international coeliac disease associations, journalists and nutritional specialists participated in the final conference held from 21 to 22 March. The goal of the research is to revive the cultivation of the cereals and pseudo cereals in the alpine region, study high-performance varieties and develop gluten-free foods.

Dr. Schär has signed an agreement on a strategic alliance with the Finnish company Raisio.
Raisio is a forerunner in cholesterol-lowering functional foods and an innovative expert in Finnish oats. Combined expertise of the companies opens new commercial opportunities for both.

To the women on our team, who contribute your women’s intuition, fight for your ideas, always keep us guessing, demonstrate their total commitment and are just so versatile.

Our products follow a continuous improvement process. This way we meet the growing expectations of the consumers.

Explaining PKU and its day-to-day management through the eyes of patients and their families is the aim of the project Mevalia #PKUHeroes.

Dr. Schär Brazil organized a big event for over 40 digital influencers of the gluten free world. The meeting happened at the city of Campo Largo, in the new company plant.

Digital transformation of businesses, particularly with regard to employees, is currently a much-discussed issue. Recently, business leaders met with each other at the Dr. Schär headquarters to discuss this topic.